{"schema_version":"secwatch.filing_event.v1","accession":"0001779372-21-000003","form_type":"8-K","ticker":"BEAT","cik":"0001779372","company_name":"HeartBeam, Inc.","filed_at":"2021-12-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.079596+00:00","generated_at":"2026-06-27T22:22:16.545560+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"HeartBeam appoints Alan Baumel as COO effective Dec 20, 2021","bullets":["Annual salary of $200,000, bonus eligibility post-IPO, and option for 1% of post-IPO shares.","Bring 35+ years MedTech experience; previously SVP at Bardy Diagnostics (Hillrom) and roles at Gore, Medtronic, Boston Scientific-acquired firms.","Will lead product development, manufacturing, quality, and regulatory affairs to accelerate commercialization."],"urls":{"canonical":"https://secwatch.observer/filing/0001779372-21-000003","json":"https://secwatch.observer/filing/0001779372-21-000003.json","markdown":"https://secwatch.observer/filing/0001779372-21-000003.md","text":"https://secwatch.observer/filing/0001779372-21-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1779372/000177937221000003/0001779372-21-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1779372/000177937221000003/form8k-12202021.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T22:22:16.545560+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5035b625a8","claim":"Alan Baumel was appointed as Chief Operating Officer at HeartBeam, Inc..","evidence_excerpt":"On December 20, 2021, the Board of Directors (the “Board”) of HeartBeam, Inc. (the “Company”) appointed Alan Baumel as Chief Operating Office of the Company (the “Appointment”) effective as of December 20, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1779372/000177937221000003/0001779372-21-000003-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}